Barry E. Greene founded Vicarious Surgical, Inc. Presently, Dr. Greene is President, Chief Executive Officer & Director at SAGE Therapeutics, Inc.

He is also on the board of Acorda Therapeutics, Inc., Karyopharm Therapeutics, Inc. and BCLS Acquisition Corp. and Chief Medical Officer at Vicarious Surgical, Inc.

In the past he was President of Alnylam Pharmaceuticals, Inc., Partner at Andersen Consulting LLP (GB), Vice President-Marketing & Customer Services at AstraZeneca Plc and Vice President-Strategic Integration at AstraZeneca Pharmaceuticals LP (a subsidiary of AstraZeneca Plc), Partner at Accenture Ltd., Chief Business Officer & Executive Vice President at Mediconsult.com, Inc. and General Manager-Oncology Division at Millennium Pharmaceuticals, Inc.

Dr. Greene received an undergraduate degree from the University of Pittsburgh.